153 related articles for article (PubMed ID: 6803307)
21. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
22. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
23. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
[TBL] [Abstract][Full Text] [Related]
24. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
Ehrman ML; Jaffe EA
Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
[TBL] [Abstract][Full Text] [Related]
25. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
26. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
27. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
Norris LA; Devitt M; Bonnar J
Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
[TBL] [Abstract][Full Text] [Related]
28. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
[TBL] [Abstract][Full Text] [Related]
29. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
30. Congenital deficiency of thromboxane and prostacyclin.
Pareti FI; Mannucci PM; D'Angelo A; Smith JB; Sautebin L; Galli G
Lancet; 1980 Apr; 1(8174):898-901. PubMed ID: 6103258
[TBL] [Abstract][Full Text] [Related]
31. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandins and platelets.
Mustard JF; Kinlough-Rathbone RL; Packham MA
Annu Rev Med; 1980; 31():89-96. PubMed ID: 6994628
[TBL] [Abstract][Full Text] [Related]
33. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?
Sinzinger H; Silberbauer K; Horsch AK; Gall A
Prostaglandins; 1981 Jan; 21(1):49-51. PubMed ID: 7010457
[TBL] [Abstract][Full Text] [Related]
34. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
35. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Schafer AI; Crawford DD; Gimbrone MA
J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
[TBL] [Abstract][Full Text] [Related]
36. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
Hanasaki K; Nakano T; Arita H
Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
[TBL] [Abstract][Full Text] [Related]
37. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
[TBL] [Abstract][Full Text] [Related]
38. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
39. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
[TBL] [Abstract][Full Text] [Related]
40. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
